This book gives a comprehensive account of the practical aspects of PCR and strong consideration is given to ensure its optimal use in a laboratory environment. This includes the setting-up of a PCR ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the availability of two custom-designed ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.

ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions ...

DeepChek® NGS ecosystem maps viral resistance mutations to next-generation therapies, unlocking new insights for ...

When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years, digital PCR (dPCR) has captured the attention of researchers and clinicians ...

Countable Labs raises $26 million. Company shares plans for new products to support clinical testing applications and announces hire of sales leader.

Laboratories performing diagnostic testing for infectious diseases have an obligation to meet the needs of multiple patient populations. With infectious disease, time it takes for reporting can have ...

DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. PCR is a powerful molecular biology ...